Metformin as a booster of cancer immunotherapy.
Int Immunopharmacol
; 121: 110528, 2023 Aug.
Article
in En
| MEDLINE
| ID: mdl-37364322
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Metformin
/
Neoplasms
Limits:
Humans
Language:
En
Journal:
Int Immunopharmacol
Journal subject:
ALERGIA E IMUNOLOGIA
/
FARMACOLOGIA
Year:
2023
Document type:
Article
Affiliation country:
Japan
Country of publication:
Netherlands